Vimta Labs Ltd.

Financial

	Vimta Labs	Krsnaa Diagnostics	Nephro Care India
Operational Metrics
Pharmaceutical Sector
R&D as a % of Total Sales	0.71 %	n/a	n/a
Financials
5 yr Average ROE	12.51 %	32.72 %	223.01 %
5yr average Equity Multiplier	1.33	1.71	29.25
5yr Average Asset Turnover Ratio	0.82	0.57	1.48
5yr Avg Net Profit Margin	11.37 %	24.81 %	5.31 %
Price to Book	3.81	2.77	0.0
P/E	29.68	39.54	265.2
5yr Avg Cash Conversion Cycle	122.88 Days	-281.13 Days	-39.85 Days
Inventory Days	26.64 Days	8.61 Days	7.49 Days
Days Receivable	95.75 Days	49.07 Days	2.5 Days
Days Payable	315.03 Days	358.5 Days	79.87 Days
5yr Average Interest Coverage Ratio	21.55	9.83	8.33
5yr Avg ROCE	16.46 %	33.72 %	27.74 %
5yr Avg Operating Profit Margin	26.52 %	50.58 %	11.33 %
5 yr average Debt to Equity	0.11	0.37	17.44
5yr CAGR Net Profit	43.08 %	-19.6 %	84.8 %
5yr Average Return on Assets	9.62 %	15.0 %	10.43 %
Shareholdings
Promoter Holding	36.89 %	27.17 %	n/a
Share Pledged by Promoters	0.0	0.0	n/a
Change in Promoter Holding (3 Yrs)	-0.57 %	-0.21 %	n/a
Change in Mutual Fund Holding (3 Yrs)	1.49 %	2.3 %	n/a

Business

	Vimta Labs	Krsnaa Diagnostics	Nephro Care India
Product Wise Break-Up	Product Wise Break-Up Testing and Analysis 100.0 Tele Reporting 0 Pathology 0 Radiology 0 Dialysis & Pathology Centre 0	Product Wise Break-Up Testing and Analysis 0 Radiology 55.9 Pathology 33.8 Dialysis & Pathology Centre 0 Tele Reporting 10.2 Others 0.1	Product Wise Break-Up Testing and Analysis 0 Radiology 0 Pathology 0 Dialysis & Pathology Centre 100.0 Tele Reporting 0
Location Wise Break-Up	Location Wise Break-Up India 72.78 International 27.22 West India 0 East India 0 South India 0 North India 0	Location Wise Break-Up International 0 India 0 East India 5.0 West India 44.0 North India 28.0 South India 23.0	Location Wise Break-Up International 0 India 100.0 East India 0 West India 0 North India 0 South India 0